Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zintl

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Klinische Padiatrie|November 1, 1995
[Therapy-induced formation of ascites and pleural effusion during initial chemotherapy in a patient with non-Hodgkin's lymphoma. Ascites and pleural effusion during initial chemotherapy]B Gruhn, D Fuchs, J Hermann, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 19, 2002
Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasmaK Kentouche, U Budde, M Furlan, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Immunoreconstitution after human bone marrow transplantationF Zintl, J Prager, A Sauerbrey, et al.
Journal of Medical Virology|September 6, 2001
Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseasesA Meerbach, B Gruhn, R Egerer, et al.
Klinische Padiatrie|July 1, 1996
[Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogenic bone marrow transplantation]D Körholz, L Hempel, J Packeisen, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin)F Zintl, I Färber, J Hermann, et al.
Bone Marrow Transplantation|May 30, 2003
Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantationB Gruhn, A Meerbach, R Häfer, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1983
[Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells]H Thränhardt, R Soeberdt, A König, et al.
Respiration; International Review of Thoracic Diseases|June 10, 2006
Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->AJ Mainz, U Hammer, C Rokahr, et al.
Bone Marrow Transplantation|October 27, 1997
High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantationL Hempel, D Körholz, P Nussbaum, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Klinische Padiatrie|November 1, 1995
[Therapy-induced formation of ascites and pleural effusion during initial chemotherapy in a patient with non-Hodgkin's lymphoma. Ascites and pleural effusion during initial chemotherapy]B Gruhn, D Fuchs, J Hermann, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 19, 2002
Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasmaK Kentouche, U Budde, M Furlan, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Immunoreconstitution after human bone marrow transplantationF Zintl, J Prager, A Sauerbrey, et al.
Journal of Medical Virology|September 6, 2001
Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseasesA Meerbach, B Gruhn, R Egerer, et al.
Klinische Padiatrie|July 1, 1996
[Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogenic bone marrow transplantation]D Körholz, L Hempel, J Packeisen, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin)F Zintl, I Färber, J Hermann, et al.
Bone Marrow Transplantation|May 30, 2003
Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantationB Gruhn, A Meerbach, R Häfer, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1983
[Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells]H Thränhardt, R Soeberdt, A König, et al.
Respiration; International Review of Thoracic Diseases|June 10, 2006
Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->AJ Mainz, U Hammer, C Rokahr, et al.
Bone Marrow Transplantation|October 27, 1997
High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantationL Hempel, D Körholz, P Nussbaum, et al.
Pageof 19